FDA
approval
· 2019-06-11
FDA Approved: TESTOSTERONE — Supplemental Application (Actavis Pharma, Inc.)
Summary
FDA approved a supplemental application for a generic testosterone product from Actavis Pharma (ANDA205328).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TESTOSTERONE (TESTOSTERONE)